Dapagliflozin for Cardio-renal Protection After ICU Discharge
Dapagliflozin for Cardio-renal Protection After ICU Discharge
Recruiting · NCT07025629 · Registry updated 2026-02-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dapagliflozin for Cardio-renal Protection After ICU Discharge | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, cardio-renal syndrome, cardiovascular disorder, heart disorder, heart failure, kidney disorder, kidney failure, urinary system disorder | Recruiting | Phase 3 | 2026-02-23 | NCT07025629 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 985 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hospital Saint Louis | Paris | France | 9 |
| Saint Louis Hospital | Paris | France | 6 |